Barbara Cebula-Obrzut

5PUBLICATIONS
9CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsHaematological tumoursCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
Evaluation of mTOR, NFκB and BCL-2 Inhibitor Activity In Vitro in Karpas 1106P, a Primary Mediastinal B-Cell Lymphoma Cell Line.

|Feb 27, 2026
Evaluation of mTOR, NFκB, and BCL-2 Inhibitor Activity In Vitro on Diffuse Large B-Cell Lymphoma Cells.

Agata Majchrzak, Sylwia Mańka, Barbara Cebula-Obrzut

|Sep 28, 2023
Cytotoxic Activity of Melatonin Alone and in Combination with Doxorubicin and/or Dexamethasone on Diffuse Large B-Cell Lymphoma Cells in In Vitro Conditions.

Sylwia Mańka, Piotr Smolewski, Barbara Cebula-Obrzut

|Sep 28, 2023
Atypical Chronic Lymphocytic Leukemia-The Current Status.

Tadeusz Robak, Anna Krawczyńska, Barbara Cebula-Obrzut

|Dec 15, 2018
Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells.

Katarzyna Lubecka, Agnieszka Kaufman-Szymczyk, Barbara Cebula-Obrzut

Pageof 1

Frequent Collaborators

2 joint publications

Sylwia Mańka

2 joint publications

Agata Majchrzak

2 joint publications

Magdalena Witkowska

1 joint publications

Katarzyna Lubecka